Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 15, Number 1—January 2009


Linezolid-Resistant Staphylococcus cohnii, Greece

Efi PetinakiComments to Author , Maria Kanellopoulou, Anthi Damani, Antigoni Foka, Iris Spiliopoulou, Nikoletta Skalmoutsou, Bogdan Raitsiou, Konstantinos Valakis, and Evangelos Papafragas
Author affiliations: University of Thessalia, Larissa, Greece (E. Petinaki); Sismanoglion General Hospital of Athens, Athens, Greece (M. Kanellopoulou, N. Skalmoutsou, B. Raitsiou, K.Valakis, E. Papafragas); Institute of BioMedical Research and Technology, Larissa (E. Petinaki, A. Damani); University of Patras, Patras, Greece (A. Foka, I. Spiliopoulou)

Main Article


Clinical characteristics of 4 patients from whom linezolid-resistant Staphylococcus cohnii was isolated, Greece, 2007*

Patient no. Gender/ age, y Medical
history Reason
for hospitalization Previous treatment Date of hospital admission Date of sample collection Outcome Date of death or discharge
1 F/82 No relevant history Acute cholecystitis, necrotizing pancreatitis CIP, CAZ, IMP, TZP, LIN May 10 Jul 20 Death Aug 21
2 M/38 Alcoholism Lung abscess CIP, CAZ, LIN Jul 14 Aug 21 Recovery Oct 20
3 M/52 COPD, melitensus diabetes Necrotizing pneumonia TZP, CLI, IMP, LIN Aug 21 Sep 25 Recovery Oct 30
4 M/65 No relevant history Septic shock IMP, CIP, TZP, LIN Sep 17 Oct 28 Recovery Dec 10

*CIP, ciprofloxacin; CAZ, ceftazidime; IMP, imipenem; TZP, piperacillin-tazobactam; LIN, linezolid; CLI, clindamycin; COPD, chronic obstructive pulmonary disease.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO